Maho Egusa
Yamaguchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Concurrent low skeletal muscle mass and fat area may predict poor survival in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy.
Journal: Clinical nutrition ESPEN
Published: June 13, 2026
A Novel Diagnostic Approach for Hepatocellular Carcinoma Using Glycosylated Ferritin.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 18, 2025
Development of a novel scoring system to determine the optimal timing of esophagogastroduodenoscopy following portosystemic shunt occlusion.
Journal: PloS one
Published: October 21, 2025
Caution Regarding Short-Term Increases in Ammonia Levels Following Splenic Artery Embolization.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 18, 2025
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension.
Journal: Journal of gastroenterology
Published: November 15, 2022
Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 21, 2022
Screening for portopulmonary hypertension using computed tomography-based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 03, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026